Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The sweet taste receptor is a heterodimeric Class C G protein-coupled receptor (GPCR) composed of the Taste receptor type 1 member 2 (TAS1R2) and Taste receptor type 1 member 3 (TAS1R3) subunits [4, 6, 12]. Primarily localized in the taste buds of the tongue, it functions as the principal sensor for sweet-tasting substances, including caloric sugars, high-potency artificial sweeteners, and certain sweet proteins [1, 8, 13]. Beyond the oral cavity, the receptor is expressed in extra-oral tissues such as the gastrointestinal tract, pancreas, and brain, where it plays a critical role in nutrient sensing and energy homeostasis [3, 6, 10]. In the gut, activation of these receptors by sugars or sweeteners triggers the release of metabolic hormones like glucagon-like peptide-1 (GLP-1), which modulates insulin secretion and glucose absorption [10, 11, 15]. Because of its central role in dietary choice and metabolic signaling, the receptor is a major target for both the food industry and pharmaceutical research focused on obesity and type 2 diabetes [6, 9, 12]. Interactions with various ligands, ranging from natural sweeteners to pharmacological inhibitors like lactisole, highlight its potential for therapeutic modulation and the complexity of its long-term impact on metabolic health [11, 15, 17].
Binding of a sweet ligand to the extracellular Venus Flytrap domains of the TAS1R2/TAS1R3 heterodimer induces a conformational change that activates the heterotrimeric G-protein gustducin [1, 12, 13]. This triggers a signaling cascade involving the activation of phospholipase C beta 2 (PLCβ2), leading to the generation of inositol trisphosphate (IP3) and subsequent release of intracellular calcium [4, 10, 11]. The elevation of calcium levels opens the transient receptor potential cation channel M5 (TRPM5), causing cell depolarization and the release of ATP as a neurotransmitter to signal sweetness to the brain or trigger hormonal responses in extra-oral tissues [3, 7, 8].
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taste receptor type 1 member 2 and Taste receptor type 1 member 3 heterodimer (Sweet taste receptor) (TAS1R2/TAS1R3).